Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NADOLOL vs NALMEFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NADOLOL vs NALMEFENE: Safety Overview

Metric NADOLOL NALMEFENE
Total FAERS Reports 1,878 197
Deaths Reported 141 77
Death Rate 7.5% 39.1%
Hospitalizations 607 118
Average Patient Age 57.0 yrs 44.2 yrs
% Female Patients 84.2% 39.3%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 17, 1995
Manufacturer American Health Packaging Purdue Pharma L.P.
Route ORAL INTRAMUSCULAR
Marketing Status Discontinued Discontinued